Generic Name: Sitagliptin Phosphate / Metformin HCI

Brand Name: Velmetia™

Strength: Sitagliptin Phosphate 50 mg / Metformin HCI 1 g

Form: Film-Coated Tablet

Manufacturer: Patheon Puerto Rico, Inc Packed by: Hangzhou MSD Pharmaceutical Co., Ltd. Imported by: Merck Sharp & Dohme (I.A) LLC Distributed by: Essex Pharmaceuticals, Inc.

Classification: Antidiabetic

Indication/Uses:
Initial therapy in Type 2 DM to improve glycemic control when diet & exercise alone do not provide adequate glycemic control, or inadequately controlled w/ metformin or sitagliptin alone or in patients being treated w/ combination of metformin & sitagliptin.

As part of triple combination therapy w/ a sulfonylurea as an adjunct to diet & exercise in patients w/ type 2 DM inadequately controlled w/ any 2 of the 3 agents: metformin, sitagliptin, or a sulfonylurea.

As part of triple combination therapy w/ PPAR-γ agonist as an adjunct to diet & exercise in patients w/ type 2 DM inadequately controlled w/ any 2 of the 3 agents: metformin, sitagliptin, or a PPAR-γ agonist.

Type 2 DM as an adjunct to diet & exercise to improve glycemic control in combination w/ insulin.